Your browser doesn't support javascript.
loading
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia.
Both, Anna; Krauter, Jürgen; Damm, Frederik; Thol, Felicitas; Göhring, Gudrun; Heuser, Michael; Ottmann, Oliver; Lübbert, Michael; Wattad, Mohammed; Kanz, Lothar; Schlimok, Günter; Raghavachar, Aruna; Fiedler, Walter; Kirchner, Hartmut; Brugger, Wolfram; Schlegelberger, Brigitte; Heil, Gerhard; Ganser, Arnold; Wagner, Katharina.
  • Both A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.
  • Krauter J; Institute of Medical Microbiology, Virology and Hygiene, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Damm F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.
  • Thol F; Department Hematology and Oncology, Klinikum Braunschweig, Braunschweig, Germany.
  • Göhring G; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.
  • Heuser M; Department Hematology, Oncology, and Tumor Immunology, Charité-University Medicine, Berlin, Germany.
  • Ottmann O; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.
  • Lübbert M; Institute of Molecular and Cellular Pathology, Hannover Medical School, Hannover, Germany.
  • Wattad M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg Str. 1, 30625, Hannover, Germany.
  • Kanz L; Department Internal Medicine II, University of Frankfurt, Frankfurt, Germany.
  • Schlimok G; Department Internal Medicine I, University of Freiburg, Freiburg, Germany.
  • Raghavachar A; Department Hematology/Oncology, Ev. Krankenhaus Essen-Werden, Essen, Germany.
  • Fiedler W; Department Internal Medicine II, University of Tübingen, Tübingen, Germany.
  • Kirchner H; Department Internal Medicine II, Klinikum Augsburg, Augsburg, Germany.
  • Brugger W; Department Internal Medicine I, HELIOS-Klinikum Wuppertal, Wuppertal, Germany.
  • Schlegelberger B; Department of Internal Medicine II, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Heil G; Department Hematology/Oncology, Hospital Siloah, Hannover, Germany.
  • Ganser A; Department Hematology/Oncology, Schwarzwald-Baar Klinikum, Villingen-Schwenningen, Germany.
  • Wagner K; Institute of Molecular and Cellular Pathology, Hannover Medical School, Hannover, Germany.
Ann Hematol ; 96(6): 895-904, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28331964

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia Mieloide / Mutación Puntual / Telomerasa / Polimorfismo de Nucleótido Simple / Trasplante de Células Madre Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia Mieloide / Mutación Puntual / Telomerasa / Polimorfismo de Nucleótido Simple / Trasplante de Células Madre Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article